The use of an electronic Patient-Reported Outcome Measure in the management of patients with advanced chronic kidney disease – the RePROM pilot trial

niversity of Birmingham0 个研究点目标入组 66 人开始时间: 2018年2月28日最近更新: 2023年3月27日

适应症

试验速览

2018 Protocol article in https://pubmed.ncbi.nlm.nih.gov/30373785/ protocol (added 11/12/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35304391/ (added 13/03/2023)

•1. Aged =18 years old
•2. Ability to provide fully informed consent for participation in the study
•3. Patients under the care of the renal services at Queen Elizabeth Hospital Birmingham (QEHB)
•4. Patients meeting the trial definition of advanced CKD: an eGFR =6 and =15 mL/min/1.73m2 (inclusive) OR a projected risk of progression to end-stage renal failure within 2-years =20% using the 4-variable Tangri renal risk calculator

•1. Patients unwilling to use the ePROM intervention
•2. Patients who, in the opinion of the consenting professional, cannot speak, read or write English sufficiently well to complete the ePROM unaided
•3. An episode of acute kidney injury (defined in accordance with national guidelines) within the last 3 months
•4. Patients meeting the trial definition of End Stage Renal Disease (currently receiving dialysis/scheduled to start in the next 2 weeks OR received/scheduled date to receive a kidney transplant OR eGFR < = 5ml/min/1.73m2)
•5. A terminal illness that, in the opinion of the consultant consultant assessing eligibility, is likely to lead to the death of the patient within 6 months of starting participation in the study

发起方